Who owns CONNECT BIOPHARMA HLDGS LTD?
- Ticker: CNTB
- CUSIP Number: g23549101
Tip: Access positions for across all investors
Analyze quarterly positions in Connect Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Connect Biopharma Hldgs stock
Who bought or sold CONNECT BIOPHARMA HLDGS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 1.3M | $1.9M | 100% | Sep 2025 |
|
| Renaissance Technologies | 143k | $404k | -10% | Dec 2025 |
|
| Marshall Wace | 128k | $362k | 121% | Dec 2025 |
|
| OMERS Administration Corporation | 81k | $228k | 100% | Dec 2025 |
|
| Koa Wealth Management | 50k | $140k | 0% | Dec 2025 |
|
| XTX Topco | 24k | $35k | 100% | Sep 2025 |
|
| Geode Capital Management | 23k | $66k | 0% | Dec 2025 |
|
| Susquehanna International | 14k | $20k | 100% | Sep 2025 |
|
| Monograph Wealth Advisors | 11k | $17k | 100% | Sep 2025 |
|
| Hrt Financial | 11k | $15k | 100% | Sep 2025 |
|
| UBS Group | 3.2k | $8.9k | 1475% | Dec 2025 |
|
| Rhumbline Advisers | 780.00 | $2.2k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 121.00 | $178.995300 | 100% | Sep 2025 |
|
| SBI Securities | 7.00 | $10.999800 | 100% | Sep 2025 |
|